NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells
Regulatory B cells are important for preventing skin autoimmunity. Here the authors show that NFATc1 suppresses IL-10 transcription in regulatory B cells, and inhibiting NFATc1 decreases immunopathology in a mouse model of imiquimod-induced skin inflammation.
Guardado en:
Autores principales: | Hani Alrefai, Khalid Muhammad, Ronald Rudolf, Duong Anh Thuy Pham, Stefan Klein-Hessling, Amiya K. Patra, Andris Avots, Valesca Bukur, Ugur Sahin, Stefan Tenzer, Matthias Goebeler, Andreas Kerstan, Edgar Serfling |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2e83ccefff114a268fe56783c1489f9c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Correction: Corrigendum: NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells
por: Hani Alrefai, et al.
Publicado: (2016) -
A threshold level of NFATc1 activity facilitates thymocyte differentiation and opposes notch-driven leukaemia development
por: Stefan Klein-Hessling, et al.
Publicado: (2016) -
NFATc1 controls the cytotoxicity of CD8+ T cells
por: Stefan Klein-Hessling, et al.
Publicado: (2017) -
Advances in the use of topical imiquimod to treat dermatologic disorders
por: Francesco Lacarrubba, et al.
Publicado: (2008) -
Abnormal composition of microbiota in the gut and skin of imiquimod-treated mice
por: Hiroyo Shinno-Hashimoto, et al.
Publicado: (2021)